Menopause
pts with menopause
Created Date
04.18.20
Last Updated
04.20.20
Viewed 18 Times
Create multiple-choice games on Wisc-Online and play them on our Chakalaka mobile app!
But that's not all! Explore educational games created by others. Simply search by category or enter agame code number and dive into a world of learning and fun.
Download the Chakalaka mobile app here:
Topics of this game:
-
hx of irregular menses before perimenopause, AA heritage, cigarette smoking, & weight reduction diet
-
CHD, stroke, hop fx, breast cancer, endometrial cancer, colorectal cancer, osteoporosis
-
amenorrhea, vasomotor symptoms, genituourinary changes
-
tx with estrogen & progestin in women with an intact uterus & estrogen in women w/out uterus
-
HT with estrogen minimizes VMS & genitourinary symptoms related to estrogen deficiency
-
Associated with a lower risk of venous thromboembolism compared to oral formulations
-
Used at lowest effective dose and for shortest duration possible
-
Known breast or endometrial cancer, untreated endometrial hyperplasia, uncontrolled HTN
-
Gallbladder disease, increase in serum triglycerides, breast cancer, thromboembolic disease
-
Tx of moderate to severe dyspareunia
-
Lacks increased risk of breast cancer due to antiestrogenic activity in breast tissue
-
undiagnosed, abnormal vaginal bleeding, estrogen-dependent neoplasia, & hx of active thromboembolism
-
Increased risk of VTE events, CVD, and endometrial cancer
-
Bazedoxifene
-
reduces risk for developing endometrial hyperplasia
-
Tx of moderate to severe VMS
-
Bazedoxifene estrogen agonist effect
-
4-8 wks to evaluate response
User comments are currently unavailable. We apologize for the inconvenience and are working to restore this feature as soon as possible.